NCT06624969

Brief Summary

The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Dec 2028

First Submitted

Initial submission to the registry

September 17, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 3, 2024

Completed
1.6 years until next milestone

Study Start

First participant enrolled

April 23, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

May 5, 2026

Status Verified

May 1, 2026

Enrollment Period

1.7 years

First QC Date

September 17, 2024

Last Update Submit

May 4, 2026

Conditions

Keywords

pain controlorthopedicfracturehospital

Outcome Measures

Primary Outcomes (1)

  • opioid use

    Change in opioid equivalents during hospital stay from hospital admission to discharge

    From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

Secondary Outcomes (4)

  • reduction in anxiolytics

    From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

  • hospital length of stay

    From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

  • reduction in sleep aids prescribed

    From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

  • User experiences

    obtained once on the day of hospital discharge, up to 5 weeks from study enrollment

Study Arms (2)

Virtual reality

EXPERIMENTAL

Intervention with virtual reality

Other: virtual reality

Standard of care

NO INTERVENTION

No virtual reality intervention

Interventions

Virtual reality program to reduce pain in orthopedic fractures

Virtual reality

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized with an orthopedic fracture
  • Able to participate fully in all aspects of the study
  • Able to understand and sign informed consent
  • Individuals with unaided vision or those who can correct their vision using contact lenses

You may not qualify if:

  • Non-English speaking
  • Self-reported history of acute and/or chronic severe motion sickness
  • The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted display.
  • Legally blind or deaf
  • Have had a seizure within the past 1 year
  • Have current (within the past 30 days) clinically significant acute or chronic progressive or unstable/uncontrolled neurologic disorder
  • Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Hospital

Jacksonville, Florida, 32224, United States

RECRUITING

MeSH Terms

Conditions

Fractures, BoneAgnosia

Condition Hierarchy (Ancestors)

Wounds and InjuriesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Scott Helgeson, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Scott Helgeson, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant, Assistant Professor of Medicine

Study Record Dates

First Submitted

September 17, 2024

First Posted

October 3, 2024

Study Start

April 23, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

May 5, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations